Our state-of-the-art Research and Development (R&D) centre, with a dedicated workforce, is focused on developing ground-breaking technologies focused on manufacturing Active Pharmaceutical Ingredients (APIs), their intermediates and the development of new methods of analysis and testing. With a highly skilled and focused team of scientists we are bringing forth ground-breaking products to our ever-expanding portfolio.
Focus through this centre is to:
• To develop the process for API’s, API Intermediates, NCE Intermediates for regulated and nonregulated markets
• To improve the process efficiency of current biological products
• To engineer more cost effective and environmentally friendly processes.
Our current projects focus on developing multiple therapeutic segments for the company, these range from:
• Antipsychotic
• Cholangitis
• Anticonvulsant / Antiepileptic
• Anticoagulant Drugs
• Antiparkinsonian
• Anaesthetic Drugs
• Bile Acid Disorder
• Antituberculosis
We are currently working on:
• Daltaparin Sodium
• Bovine pancreatin
• Pepsin
• Cholic acid and its derivatives
• Trypsin
• Collagen
Driving innovations from Farm to Pharma:
Bactochem has been a market leader in the bio-pharmaceutical sector for over 4 decades, delivering on the vision “To develop research-backed innovative and affordable biological products to treat lifestyle disorders and to provide life-saving critical care”. The primary manufacturing facility is based at Hyderabad, Telangana, where Heparin Sodium (anticoagulant), Enoxaparin Sodium (anticoagulant), Chondroitin Sulphate (prophylaxis in Rheumatoid Arthritis and Osteo Arthritis), and Liver Injection Crude are manufactured.